Related Experiment Video
Updated: Sep 10, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study
Deniz Güllü1, Defne Yigci2, Nurcan Baykam3
1School of Medicine, Koç University, Istanbul, Türkiye; Graduate School of Health Sciences, Koç University, Istanbul, Türkiye; Koç University İşbank Center for Infectious Diseases (KUISCID), Koç University, Istanbul, Türkiye.
Insights
Age and diabetes are key predictors of mortality in Crimean-Congo Hemorrhagic Fever (CCHF). Early ribavirin treatment may improve survival rates for CCHF patients.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Crimean-Congo Hemorrhagic Fever (CCHF) is a tick-borne viral disease with significant mortality.
- Identifying predictors of mortality is crucial for effective patient management and resource allocation.
- Understanding demographic and clinical features of CCHF patients in Türkiye is essential for regional health strategies.
Purpose of the Study:
- To identify key predictors of mortality in hospitalized Crimean-Congo Hemorrhagic Fever (CCHF) patients in Türkiye.
- To characterize the demographic and clinical profile of CCHF patients.
- To evaluate the impact of early ribavirin administration on CCHF patient outcomes.
Main Methods:
- Retrospective study of 1103 laboratory-confirmed CCHF patients across 18 hospitals in Türkiye (2019-2024).
- Data collected via an online system, including demographic, clinical, and treatment information.
- Statistical analyses included univariate and time-dependent Cox regression to identify mortality predictors.
Main Results:
- The study included 1103 CCHF patients; 5.1% (56/1103) mortality rate was observed.
- Age ≥50 years (OR=3.1) and diabetes mellitus (OR=4.49) were significant predictors of increased mortality.
- Early ribavirin administration (≤96 hours) was significantly associated with reduced mortality (aHR=0.21).
Conclusions:
- Age and comorbidities like diabetes mellitus are significant predictors of mortality in CCHF patients.
- Early identification of high-risk patients and timely intervention are critical for improving outcomes.
- Early administration of ribavirin shows promise in reducing CCHF-related mortality.
Objective:
This study aimed to identify key predictors of mortality in patients with Crimean-Congo haemorrhagic fever (CCHF). Our specific goals included characterizing the demographic and clinical features of hospitalized CCHF patients in Türkiye, determining the factors associated with mortality among these patients, and evaluating the impact of early ribavirin administration.
Methods:
A retrospective study was conducted on 1103 CCHF patients across 18 hospitals in Türkiye from 1 January 2019 to 20 November 2024. All data were obtained via an online data collection system by the designated physician at each centre. Patients with laboratory-confirmed CCHF infection who were hospitalized were included in the study. Univariate analyses and time-dependent Cox regression were conducted.
Results:
Of the 1103 patients, 65.7% (725/1102) were men; 87.2% (962/1103) resided in rural areas; and the mean age was 53 years. Ticks were identified as the transmission route in 68.4% (755/1103) of the cases. Comorbidities included diabetes mellitus, chronic heart disease, and hypertension; 4.6% (51/1103) of the patients developed healthcare-related infections. Intensive care unit admission was required in 8.0% (88/1103) of the patients, and the overall mortality rate was 5.1% (56/1103). In univariate analyses, age ≥50 years (odds ratio [OR], 3.1; 95% CI, 1.58-6.08; p < 0.001) and diabetes mellitus (OR, 4.49; 95% CI, 2.20-9.18; p < 0.001) were associated with increased mortality. Both variables remained statistically significant predictors in the multivariate analysis. Although early ribavirin administration, ≤96 hours from symptom onset, did not reach statistical significance in univariate analysis (OR, 0.52; 95% CI, 0.26-1.05; p = 0.065), it was significantly associated with reduced mortality in time-dependent Cox regression (adjusted hazard ratios, 0.21; 95% CI, 0.07-0.69; p = 0.010).
Discussion:
Key factors such as age and comorbidities can predict mortality in CCHF patients. Timely identification of these predictors, along with early administration of ribavirin, may contribute to improved survival and better clinical outcomes.
More Related Videos
Related Concept Videos
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Comparing the Survival Analysis of Two or More Groups
Statistical Methods for Analyzing Epidemiological Data
Causality in Epidemiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention

